Evidence-Based Cardiology / Edition 3

Hardcover (Print)
Buy New
Buy New from BN.com
Used and New from Other Sellers
Used and New from Other Sellers
from $263.33
Usually ships in 1-2 business days
(Save 28%)
Other sellers (Hardcover)
  • All (8) from $263.33   
  • New (7) from $263.33   
  • Used (1) from $448.33   


Evidence based Cardiology was first published in 1998 to universal acclaim. Now, with the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence-based practice is a more important force in health care delivery than ever.

This new third edition, written by the world’s leading cardiologists, provides graded evidence-based reviews of the major trials together with recommendations for optimum management, and now includes new grading and recommendation methodology.

This is a unique book in the field of cardiology, and the largest evidence based clinical cardiology text.

The book contains black-and-white illustrations.

Read More Show Less

Editorial Reviews

From the Publisher
"Edited by a cadre of highly respected clinical researchers and academicians, the third edition will be a welcome addition to the shelves of cardiologists or primary care physicians with an interest in the dynamic field of cardiology." (JAMA, August 11, 2010)

"The text is recommended as a reference text for cardiac centres, cardiologists, cardiac nurse specialists and academic and research institutions." (Nursing Standard, April 2010)

"The is a useful addition to the field of cardiology that expands on current comprehensive books ... .The authors have succeeded in creating a multidimensional reference that fulfills their objectives, explaining the how and why of specific interventions." (Doody's, April 2010)

Doody's Review Service
Reviewer: Carlos D Giraldo, MD (Ochsner Clinic Foundation)
Description: This is an update of an overview of the best evidence for the diagnosis and management of cardiovascular disorders. The previous edition was published in 2003.
Purpose: This book is intended to be used in two ways: as a reference for in-depth understanding of cardiovascular disorders, and as a guide to the best evidence to guide the management of specific cardiovascular conditions.
Audience: Students, physicians in training, midlevel practitioners, and practicing clinicians are the intended readers.
Features: Part I of the book's four parts addresses concepts related to evidence-based cardiology and critical appraisal. Part II is devoted to preventive strategies; part III encompasses the management of specific cardiovascular disorders; and part IV focuses on how the evidence base can be used in individual case studies. This edition includes new chapters on vascular complications in patients undergoing noncardiac surgery, occupational cardiology, ablation therapies for atrial fibrillation, adult congenital heart disease, and adjunctive therapies for coronary reperfusion. Many useful summary tables integrate state-of-the-art evidence with clinical practice challenges.
Assessment: The is a useful addition to the field of cardiology that expands on current comprehensive books, such as the Mayo Clinic Cardiology: Concise Textbook, 3rd edition, Murphy and Lloyd (Informa Healthcare, 2007), by incorporating current clinical trial data in a format that helps with clinical decision making. The authors have succeeded in creating a multidimensional reference that fulfills their objectives, explaining the how and why of specific interventions.
John F. Moran
This multiauthored text on evidence based cardiology is divided into four sections covering general concepts, prevention, complications and presentations of coronary artery disease, and clinical cases. The purpose is to present a proper balance between objective therapy and empiric therapy. The authors integrate clinical expertise with available clinical evidence based on systematic research. The authors target a wide audience consisting of undergraduate and graduate physicians. All practitioners interested in cardiovascular medicine would benefit from a reading of this text since its focus is on the practical applications of clinical research in practice. The book provides an extensive review of clinical trials in all areas of cardiovascular management. They define evidence based cardiology as a conscientious, explicit, judicious use of current best evidence in making decisions about the care of cardiac patients. The chapters range widely from discussion of sensitivity and specificity of a test to case management of patients with congestive heart failure. Quality of life measurements and health economics as well as literature searches are considered. Evidence based cardiology is divided in three grades -- A, B and C. Grade A evidence is that derived from randomized clinical trials, systematic reviews and meta-analysis. Grade B evidence comes from non-randomized studies and case control studies. Grade C evidence is best opinion from experts. There are several tables in the book that list all trials as well as pertinent findings. All illustrations are in black and white. A shortcoming of the text might be the fact that regular updates will be required as new evidence becomesavailable. There is no other text in the field quite like this one and it is recommended for all practitioners of cardiovascular medicine. It expands the material available in Hurst's the Heart, Arteries and Veins, 9th edition, by Alexander et al. (McGraw-Hill, 1997) and Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 5th edition (WB Saunders, 1997). It indirectly provides a lot of opportunities for research trials since it demonstrates gaps in our knowledge. In the final analysis, the problem with evidence based cardiology is that we need more of it.

3 Stars from Doody
Read More Show Less

Product Details

  • ISBN-13: 9781405159258
  • Publisher: Wiley
  • Publication date: 12/9/2009
  • Series: Evidence-Based Medicine Series, #25
  • Edition number: 3
  • Pages: 1240
  • Sales rank: 493,192
  • Product dimensions: 8.90 (w) x 11.00 (h) x 2.30 (d)

Meet the Author

Salim Yusuf, Professor of Medicine, Heart and Stroke Foundation Chair in Cardiology, and Director of the Population Health Research Institute, McMaster University, Hamilton, Ontario.

John Cairns Dean, Faculty of Medicine, University of British Columbia.

John Camm, Professor of Clinical Cardiology and Head of the Department of Cardiac & Vascular Sciences at St George's, University of London.

Ernest Fallen, Professor Emeritus in Cardiology and Tutor in Cardiology Residency Program, McMaster University, Hamilton, Ontario.

Bernard Gersh, Professor of Medicine, Department of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Read More Show Less

Table of Contents

List of contributors, viii

Preface to the third edition, xiv

Classification of recommendations and levels of evidence, xvi

List of abbreviations, xvii

Part I: General concepts and critical appraisal
Salim Yusuf, Editor

1 Evidence-based decision making: patient–physician interface, 3
Philip J Devereaux, Marc Pfeffer, Salim Yusuf

2 Obtaining incremental information from diagnostic tests, 14
Raymond J Gibbons

3 Clinical trials and meta-analysis, 26
Jonathan R Emberson, Colin Baigent

4 Understanding concepts related to health economics, 38
Mark A Hlatky

5 Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention, 47
Philip J Devereaux, Matthew Chan, John Eikelboom

6 Implementing evidence-based medicine in cardiology, 63
Brahmajee K Nallamothu, Thomas T Tsai, Jack V Tu

7 The application of evidence-based medicine to employment fitness standards: the transportation industries with special reference to aviation, 79
Michael Joy

Part II: Prevention of cardiovascular diseases
Salim Yusuf and John A Cairns, Editors

8 Global perspective on cardiovascular disease, 95
K Srinath Reddy

9 Avoidance of worldwide vascular deaths and total deaths from smoking, 111
Prabhat Jha, Prem Mony, James Moore, Witold Zatonski

10 Tobacco and cardiovascular disease: achieving smoking cessation in cardiac patients, 125
Andrew Pipe

11 Lipids and cardiovascular disease, 138
Malcolm Law

12 Use of lipid-lowering agents in the prevention of cardiovascular disease, 147
R Alan Failor, Jeffrey L Probstfi eld

13 Blood pressure and cardiovascular disease, 165
Curt D Furberg, Bruce M Psaty, Elsayed Z Soliman

14 Dysglycemia and the risk of cardiovascular events, 179
Hertzel C Gerstein, Zubin Punthakee

15 Physical activity and exercise in cardiovascular disease prevention and rehabilitation, 190
Ray W Squires

16 Psychosocial factors, 201
Annika Rosengren

17 The social determinants of cardiovascular disease, 211
Martin McKee, Clara K Chow

18 Obesity, 221
Raj S Padwal, Arya M Sharma

19 Ethnicity and cardiovascular disease, 235
Clara K Chow, Sonia S Anand, Salim Yusuf

20 Fetal origins of coronary artery disease, 258
Katherine M Morrison, Stephanie Atkinson, Koon K Teo

21 Genetics of coronary heart disease, 268
Michael S Cunnington, Bernard D Keavney

22 Molecular genetics of cardiovascular disorders, 288
Ali J Marian, Robert Roberts

23 Diet and cardiovascular disease, 304
K Srinath Reddy

24 Integrating approaches to prevention of cardiovascular disease, 328
David A Wood, Kornelia Kotseva

Part IIIa: Stable coronary artery disease
John A Cairns and Bernard J Gersh, Editors

25 Medical management of stable coronary artery disease, 345
William E Boden

26 Percutaneous intervention, 357
David A Wood, Rohit Khurana, Christopher E Buller

27 Surgical coronary artery revascularization, 379
Morgan L Brown, Thoralf M Sundt III

28 Comparisons of percutaneous coronary intervention and coronary artery bypass grafting, 392
Arashk Motiei, Thoralf M Sundt III, Charanjit S Rihal

Part IIIb: Acute coronary syndromes
John A Cairns and Bernard J Gersh, Editors

29 Non-ST segment elevation acute coronary syndromes: unstable angina and non-ST segment elevation myocardial infarction, 409
Pierre Theroux, John A Cairns

30 Early prehospital management of ST segment elevation myocardial infarction, 444
Robert C Welsh, Paul W Armstrong

31 Reperfusion therapies for ST segment elevation myocardial infarction, 456
Joseph B Muhlestein, Jeffrey L Anderson

32 Antithrombotic therapies for patients with ST segment elevation myocardial infarction, 475
Andrew J Lucking, Keith A A Fox

33 Complications after myocardial infarction, 495
Peter L Thompson

34 An integrated approach to the management of patients after the early phase of ST segment elevation myocardial infarction, 516
Pedro L Sánchez, Francisco Fernández- Avilés

Part IIIc: Arrhythmias
A John Camm and John A Cairns, Editors

35 Atrial fibrillation: rhythm and rate control therapies, 531
Irina Savelieva, Albert L Waldo, A John Camm

36 Atrial fi brillation: upstream therapies, 568
Antonios Kourliouros, Irina Savelieva, Marjan Jahangiri, A John Camm

37 Atrial fibrillation: antithrombotic therapy, 581
John A Cairns, Stuart Connolly

38 Ablation therapy for atrial fi brillation, 596
Conor D Barrett, Chi Keong Ching, Luigi Di Biase, Claude S Elayi, David J Burkhardt, Rodney Horton, Andrea Natale

39 Supraventricular tachycardia, 606
Erica D Penny-Peterson, Gerald V Naccarelli

40 Prevention and treatment of life-threatening ventricular arrhythmia and sudden death, 619
Carlos A Morillo, Adrian Baranchuk

41 Pacemaker therapy, including cardiac resynchronization therapy, 636
William D Toff, A John Camm

42 Syncope, 673
David G Benditt, Fei Lu, Scott Sakaguchi

43 Cardiopulmonary resuscitation, 692
Michael Colquhoun

44 Arrhythmias due to monogenic disorders, 706
Dawood Darbar, Prince Kannankeril, Dan M L Roden

45 Arrhythmiagenic right ventricular cardiomyopathy, 721
Deirdre Ward, Perry M Elliott

Part IIId: Specifi c cardiovascular disorders: left ventricular dysfunction
Salim Yusuf, Editor

46 Epidemiology and prevention of heart failure and management of asymptomatic left ventricular systolic dysfunction, 735
J Paul Rocchiccioli, John J V McMurray

47 Management of overt heart failure, 756
Paul J Hauptman, Karl Swedberg

48 Acute myocarditis and dilated cardiomyopathy, 784
Leslie T Cooper Jr, Oyere K Onuma

49 Management of hypertrophic cardiomyopathy, 796
Barry J Maron

50 Infective and infi ltrative cardiomyopathies, 808
Stavros Kounas, Perry M Elliott

51 Chagas’ heart disease, 823
J Antonio Marin-Neto, Anis Rassi Jr, Benedito Carlos Maciel, Marcus Vinicius Simões, André Schmidt

Part IIIe: Specifi c cardiovascular disorders: pericardial disease
Bernard J Gersh, Editor

52 Pericardial disease: an evidence-based approach to clinical management, 845
Faisal F Syed, Bongani M Mayosi

Part IIIf: Specifi c cardiovascular disorders: valvular heart disease
Bernard J Gersh, Editor

53 Rheumatic heart disease: prevention and acute treatment, 861
Bongani M Mayosi, Patrick J Commerford

54 Mitral valve disease: indications for surgery, 869
Blase A Carabello

55 Surgical indications in aortic valve disease, 878
Sunil Mankad, Heidi M Connolly, Shahbudin H Rahimtoola

56 Non-surgical aortic valve therapy: balloon valvuloplasty and transcatheter aortic valve replacement, 896
Robert H Boone, John G Webb

57 Balloon valvuloplasty: mitral valve, 913
Zoltan G Turi

58 Valve repair and choice of valve, 927
Shafie S Fazel, Tirone E David

59 Infective endocarditis, 941
Zainab Samad, Andrew Wang

60 Antithrombotic therapy after heart valve replacement, 957
Jack C J Sun, John W Eikelboom

Part IIIg: Specifi c cardiovascular disorders: other conditions
Bernard J Gersh and Salim Yusuf, Editors

61 Stroke, 971
Brian H Buck, Ashfaq Shuaib, Craig Anderson

62 Heart disease and pregnancy, 993
Rachel M Wald, Samuel C Siu

63 Adult congenital heart disease, 1006
Elisabeth Bédard, Michael A Gatzoulis

64 Venous thromboembolic disease, 1032
Lori-Ann Linkins, Clive Kearon

65 Peripheral arterial disease, 1050
Catherine McGorrian, Sonia S Anand

66 Cardiac risk in those undergoing non-cardiac surgery, 1068
Ameeth Vedre, Kim A Eagle

67 Clinical management of diseases of the aorta, 1079
Thoralf M Sundt III

68 Cardiac transplantation: indications and postoperative management, 1099
Barry Boilson, Sudhir Kushwaha

69 Renal dysfunction, 1110
Johannes F E Mann, Ernesto L Schiffrin

70 Pulmonary hypertension, 1118
Brendan P Madden

Part IV: Clinical applications
Ernest L Fallen, Editor

71 Clinical applications of external evidence, 1135
Ernest L Fallen, Salim Yusuf

72 Stable angina: choice of PCI versus CABG versus drugs, 1138
William S Weintraub

73 Non-ST segment acute coronary syndrome, 1142
David Fitchett

74 Acute ST segment elevation myocardial infarction, 1152
Ernest L Fallen

75 Secondary prevention strategies post myocardial infarction, 1157
Jacques Genest

76 Heart failure, 1164
Michael M Givertz, Garrick C Stewart

77 Atrial fibrillation, 1170
Michael Klein

78 The case for and against implantable cardioverter defibrillators in patients with coronary artery disease, 1174
Jeffrey S Healey

79 Bradyarrhythmias – choice of pacemakers, 1178
Pablo B Nery, Carlos A Morillo

80 Peripheral arterial disease with suspect coronary artery disease, 1183
Victor Aboyans, Michael H Criqui

81 Valvular heart disease: timing of surgery, 1187
Jon-David R Schwalm, Victor Chu

Index, 1191

The colour plate section can be found facing p. 941

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)